The "Role of Nitroxoline in Cancer Prevention" has garnered significant attention in recent years, as researchers explore its potential therapeutic benefits beyond its traditional use as an antibiotic. According to a study published in the Journal of Medicinal Chemistry, nitroxoline exhibits anticancer properties by inducing apoptosis in various cancer cell lines and inhibiting tumor growth. The World Health Organization reports that cancer accounted for nearly 10 million deaths globally in 2020, emphasizing the urgent need for innovative preventive strategies. As the focus shifts towards repurposing existing medications for cancer prevention, nitroxoline stands out due to its favorable safety profile and the increasing body of evidence supporting its mechanism of action in disrupting cancer cell proliferation. This article delves into the multifaceted role of nitroxoline in cancer prevention, highlighting both its biochemical pathways and promising clinical data that underpin its potential as a novel therapeutic agent in oncology.